Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infectious Disease by Haemophilus Influenzae Type b”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Study completedNCT00317174
What this trial is testing

Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.

Who this might be right for
Haemophilus Influenzae Type bTetanusWhole Cell Pertussis+2 more
GlaxoSmithKline 450
Testing effectiveness (Phase 2)Study completedNCT00289796
What this trial is testing

Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine

Who this might be right for
Hepatitis B
GlaxoSmithKline 121
Large-scale testing (Phase 3)Study completedNCT01019772
What this trial is testing

Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age

Who this might be right for
Infectious Disease by Haemophilus Influenzae Type b
LG Life Sciences 217
Large-scale testing (Phase 3)Study completedNCT02428491
What this trial is testing

Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Sanofi Pasteur, a Sanofi Company 354
Large-scale testing (Phase 3)Study completedNCT01362517
What this trial is testing

Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B

Who this might be right for
DiphtheriaPertussisTetanus+2 more
Crucell Holland BV 131
Large-scale testing (Phase 3)Study completedNCT01251133
What this trial is testing

Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 Study

Who this might be right for
Infectious Disease by Haemophilus Influenzae Type b
LG Life Sciences 122
Large-scale testing (Phase 3)Study completedNCT01457560
What this trial is testing

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine

Who this might be right for
Hepatitis BAcellular PertussisHaemophilus Influenzae Type b+3 more
GlaxoSmithKline 80
Not applicableStudy completedNCT03931239
What this trial is testing

The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Vabiotech 222
Large-scale testing (Phase 3)Study completedNCT00169442
What this trial is testing

Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants

Who this might be right for
Whole Cell PertussisDiphtheriaHepatitis B+2 more
GlaxoSmithKline 745